Plant-Based Infant Formula — Soy Isoflavone Exposure in Infants (Phytoestrogen Dose per Body Weight, AAP Guidance, Endocrine Concern) — food safety profile

What is this product?

Soy-based infant formulas (Enfamil ProSobee, Similac Soy Isomil, Gerber Good Start Soy) deliver soy protein isolate as the sole protein source, providing infants with 6-12 mg/kg body weight/day of soy isoflavones (genistein and daidzein) — circulating blood levels 13,000-22,000 times higher than endogenous estradiol in infants. This phytoestrogen exposure is unique to soy formula-fed infants: breastfed and cow-milk formula-fed infants receive negligible isoflavone exposure. Soy isoflavones are selective estrogen receptor modulators (SERMs) that bind ERalpha and ERbeta, with tissue-dependent agonist/antagonist activity. Animal studies in rodents and non-human primates demonstrate effects on reproductive development, thyroid function, and immune maturation at exposures comparable to soy formula-fed human infants. However, longitudinal human studies (including the Beginnings study following 283 soy formula-fed infants) have not demonstrated clinically significant adverse reproductive or developmental outcomes through adolescence, though subtle differences in reproductive tissue composition (uterine volume, menstrual characteristics) have been reported. The AAP (American Academy of Pediatrics) recommends soy formula only for specific medical indications (galactosemia, congenital lactase deficiency, cultural/religious preference for vegan diet) and states it should NOT be used routinely as an alternative to cow-milk formula, for colic management, or for perceived milk intolerance without diagnosis.

What's in it

Click any compound name for its full safety profile, regulatory consensus, and exposure data.

No compound composition on file for this product.

Frequently asked questions

No FAQs generated.